These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 8884229)
21. Effect of chronic administration of flesinoxan and fluvoxamine on freezing behavior induced by conditioned fear. Li XB; Inoue T; Hashimoto S; Koyama T Eur J Pharmacol; 2001 Aug; 425(1):43-50. PubMed ID: 11672573 [TBL] [Abstract][Full Text] [Related]
22. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats. Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491 [TBL] [Abstract][Full Text] [Related]
23. Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test. Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E Eur J Pharmacol; 2004 Mar; 487(1-3):133-42. PubMed ID: 15033385 [TBL] [Abstract][Full Text] [Related]
24. WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor. Hjorth S; Westlin D; Bengtsson HJ Neuropharmacology; 1997; 36(4-5):461-5. PubMed ID: 9225270 [TBL] [Abstract][Full Text] [Related]
25. Additive subthreshold dose effects of cannabinoid CB(1) receptor antagonist and selective serotonin reuptake inhibitor in antidepressant behavioral tests. Takahashi E; Katayama M; Niimi K; Itakura C Eur J Pharmacol; 2008 Jul; 589(1-3):149-56. PubMed ID: 18571641 [TBL] [Abstract][Full Text] [Related]
26. Catalepsy induced by the 5-HT(1A) receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram. Eltayb A; Svensson TH; Ahlenius S Eur J Pharmacol; 2001 Jan; 411(3):275-7. PubMed ID: 11164384 [TBL] [Abstract][Full Text] [Related]
27. Citalopram-induced hypophagia is enhanced by blockade of 5-HT(1A) receptors: role of 5-HT(2C) receptors. Grignaschi G; Invernizzi RW; Fanelli E; Fracasso C; Caccia S; Samanin R Br J Pharmacol; 1998 Aug; 124(8):1781-7. PubMed ID: 9756397 [TBL] [Abstract][Full Text] [Related]
28. Target brain sites of the anxiolytic effect of citalopram, a selective serotonin reuptake inhibitor. Izumi T; Inoue T; Kitaichi Y; Nakagawa S; Koyama T Eur J Pharmacol; 2006 Mar; 534(1-3):129-32. PubMed ID: 16494863 [TBL] [Abstract][Full Text] [Related]
29. Serotonergic activation reduces defensive freezing in the conditioned fear paradigm. Inoue T; Tsuchiya K; Koyama T Pharmacol Biochem Behav; 1996 Apr; 53(4):825-31. PubMed ID: 8801584 [TBL] [Abstract][Full Text] [Related]
30. Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures. Clinckers R; Smolders I; Meurs A; Ebinger G; Michotte Y Neuropharmacology; 2004 Dec; 47(7):1053-61. PubMed ID: 15555639 [TBL] [Abstract][Full Text] [Related]
31. Involvement of spinal serotonin receptors in the regulation of intraspinal acetylcholine release. Kommalage M; Höglund AU Eur J Pharmacol; 2005 Feb; 509(2-3):127-34. PubMed ID: 15733547 [TBL] [Abstract][Full Text] [Related]
32. alpha(2)-Adrenoceptor involvement in the in vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons. Grandoso L; Torrecilla M; Pineda J; Ugedo L Eur J Pharmacol; 2005 Jul; 517(1-2):51-8. PubMed ID: 15975573 [TBL] [Abstract][Full Text] [Related]
34. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors. Hjorth S; Auerbach SB Eur J Pharmacol; 1994 Aug; 260(2-3):251-5. PubMed ID: 7988652 [TBL] [Abstract][Full Text] [Related]
35. Synergistic actions of the 5-HT1A receptor antagonist WAY-100635 and citalopram on male rat ejaculatory behavior. Ahlenius S; Larsson K Eur J Pharmacol; 1999 Aug; 379(1):1-6. PubMed ID: 10499366 [TBL] [Abstract][Full Text] [Related]
36. Triple reuptake inhibition of serotonin, norepinephrine, and dopamine increases the tonic activation of α Jiang JL; El Mansari M; Blier P Prog Neuropsychopharmacol Biol Psychiatry; 2020 Dec; 103():109987. PubMed ID: 32474007 [TBL] [Abstract][Full Text] [Related]
37. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent. Pałucha-Poniewiera A; Brański P; Lenda T; Pilc A J Pharmacol Exp Ther; 2010 Sep; 334(3):1066-74. PubMed ID: 20562216 [TBL] [Abstract][Full Text] [Related]
38. Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex. Huang M; Ichiwaka J; Li Z; Dai J; Meltzer HY Psychopharmacology (Berl); 2006 Apr; 185(3):274-81. PubMed ID: 16521036 [TBL] [Abstract][Full Text] [Related]
39. Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects. Fletcher PJ; Sinyard J; Salsali M; Baker GB Psychopharmacology (Berl); 2004 Jul; 174(3):406-13. PubMed ID: 14740149 [TBL] [Abstract][Full Text] [Related]
40. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment. Gundlah C; Hjorth S; Auerbach SB Neuropharmacology; 1997; 36(4-5):475-82. PubMed ID: 9225272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]